Asep Medical Holdings Inc (SEPSF)
USD 0.39
(545.0%)
USD 0.39
(545.0%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | -7.72 Million CAD | -41.87% |
| 2022 | -5.44 Million CAD | -175.21% |
| 2021 | -1.97 Million CAD | -6938.56% |
| 2020 | -28.09 Thousand CAD | -7859.49% |
| 2019 | -353.00 CAD | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q1 | -916.91 Thousand CAD | 51.12% |
| 2024 Q2 | -1.31 Million CAD | -43.76% |
| 2023 FY | -7.72 Million CAD | -41.87% |
| 2023 Q3 | -1.62 Million CAD | 22.24% |
| 2023 Q2 | -2.09 Million CAD | -26.25% |
| 2023 Q1 | -1.65 Million CAD | -34.8% |
| 2023 Q4 | -1.87 Million CAD | -15.32% |
| 2022 Q2 | -1.5 Million CAD | 3.37% |
| 2022 Q1 | -1.55 Million CAD | -37.25% |
| 2022 FY | -5.44 Million CAD | -175.21% |
| 2022 Q4 | -1.22 Million CAD | -7.16% |
| 2022 Q3 | -1.14 Million CAD | 23.89% |
| 2021 Q2 | -97.91 Thousand CAD | -6.36% |
| 2021 FY | -1.97 Million CAD | -6938.56% |
| 2021 Q1 | -92.05 Thousand CAD | 0.0% |
| 2021 Q4 | -1.13 Million CAD | -406.89% |
| 2021 Q3 | -224.18 Thousand CAD | -128.96% |
| 2020 FY | -28.09 Thousand CAD | -7859.49% |
| 2019 FY | -353.00 CAD | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Capstone Therapeutics Corp. | -1.25 Million USD | -514.75% |
| Skye Bioscience, Inc. | -13.67 Million USD | 43.524% |
| Santhera Pharmaceuticals Holding AG | 81.85 Million USD | 109.433% |
| Nascent Biotech, Inc. | -2.22 Million USD | -246.264% |
| Qrons Inc. | -643.67 Thousand USD | -1099.556% |
| Adynxx, Inc. | - USD | Infinity% |
| BioStem Technologies, Inc. | -7.77 Million USD | 0.742% |
| CSL Limited | 3.7 Billion USD | 100.209% |
| Evofem Biosciences, Inc. | -17.84 Million USD | 56.736% |
| Arch Therapeutics, Inc. | -5.04 Million USD | -53.064% |
| Regen BioPharma, Inc. | -686.95 Thousand USD | -1023.992% |
| Northwest Biotherapeutics, Inc. | -55.5 Million USD | 86.09% |
| ProtoKinetix, Incorporated | -415.47 Thousand USD | -1758.4% |
| Rebus Holdings, Inc. | -664 Thousand USD | -1062.841% |
| Burzynski Research Institute, Inc. | -1.33 Million USD | -478.185% |
| Neon Bloom, Inc. | -389.57 Thousand USD | -1881.996% |
| Acro Biomedical Co., Ltd. | -15.86 Million USD | 51.346% |
| Eiger BioPharmaceuticals, Inc. | -71.78 Million USD | 89.244% |
| Nanobac Pharmaceuticals, Incorporated | 4.91 Million USD | 257.102% |
| Institute of Biomedical Research Corp. | -261.72 Thousand USD | -2850.132% |
| SQZ Biotechnologies Company | -75.82 Million USD | 89.817% |
| Intellipharmaceutics International Inc. | -2.85 Million USD | -170.873% |
| Propanc Biopharma, Inc. | -1.53 Million USD | -402.67% |
| Mesoblast Limited | -84.14 Million USD | 90.824% |
| Marizyme, Inc. | -34.08 Million USD | 77.348% |
| Genus plc | 6.4 Million USD | 220.645% |
| VioQuest Pharmaceuticals, Inc. | 9.74 Million USD | 179.254% |
| Pharming Group N.V. | -4.87 Million USD | -58.237% |
| Therapeutic Solutions International, Inc. | -1.98 Million USD | -288.691% |
| CNBX Pharmaceuticals Inc. | -931.38 Thousand USD | -729.013% |
| Nymox Pharmaceutical Corporation | -8.35 Million USD | 7.53% |
| ContraFect Corporation | -56.88 Million USD | 86.427% |
| PsyBio Therapeutics Corp. | -4.55 Million USD | -69.522% |
| Sienna Biopharmaceuticals, Inc. | - USD | Infinity% |
| RegeneRx Biopharmaceuticals, Inc. | -1.4 Million USD | -450.736% |
| IMV Inc. | -38.67 Million USD | 80.034% |
| AXIM Biotechnologies, Inc. | -2.75 Million USD | -180.688% |
| MultiCell Technologies, Inc. | -722.81 USD | -1068128.58% |
| ONE Bio Corp. | 13.68 Million USD | 156.436% |
| Accustem Sciences Inc. | -3.74 Million USD | -106.097% |
| RVL Pharmaceuticals plc | -58.99 Million USD | 86.911% |
| Arno Therapeutics, Inc. | - USD | Infinity% |
| EV Biologics, Inc. | -483.06 Thousand USD | -1498.4% |
| Q BioMed Inc. | -3.44 Million USD | -124.089% |
| Emmaus Life Sciences, Inc. | 3.54 Million USD | 318.115% |
| Mosaic ImmunoEngineering Inc. | -2.62 Million USD | -193.861% |
| Biomind Labs Inc. | -1 Million USD | -664.782% |
| American Oriental Bioengineering, Inc. | -54.97 Million USD | 85.954% |
| Provectus Biopharmaceuticals, Inc. | -2.9 Million USD | -166.136% |
| TetraLogic Pharmaceuticals Corporation | - USD | Infinity% |
| Oncotelic Therapeutics, Inc. | -6.64 Million USD | -16.144% |
| GlobeStar Therapeutics Corporation | -1.86 Million USD | -314.149% |
| THC Farmaceuticals, Inc. | -29.95 Thousand USD | -25678.789% |
| Curative Biotechnology, Inc. | -1.93 Million USD | -299.525% |
| GB Sciences, Inc. | -1.42 Million USD | -443.556% |
| Alpha Cognition Inc. | -9.7 Million USD | 20.445% |
| HST Global, Inc. | -140.9 Thousand USD | -5379.687% |
| Wesana Health Holdings Inc. | -1.12 Million USD | -586.392% |
| Halberd Corporation | -75.05 Thousand USD | -10188.159% |
| Enzolytics Inc. | -2.14 Million USD | -259.329% |
| Agentix Corp. | -1.37 Million USD | -462.874% |
| Resverlogix Corp. | -12.74 Million USD | 39.436% |
| Nuo Therapeutics, Inc. | -3.16 Million USD | -143.706% |
| MetaStat, Inc. | - USD | Infinity% |
| argenx SE | -425.04 Million USD | 98.183% |
| Enzon Pharmaceuticals, Inc. | -1.04 Million USD | -639.585% |
| Endonovo Therapeutics, Inc. | -2.91 Million USD | -164.477% |
| RespireRx Pharmaceuticals Inc. | -1.57 Million USD | -388.887% |
| GeneThera, Inc. | - USD | Infinity% |
| Inhibitor Therapeutics, Inc. | -3.4 Million USD | -126.764% |
| AVAX Technologies, Inc. | 6.69 Million USD | 215.365% |
| Zenith Capital Corp. | -8.94 Million USD | 13.661% |
| Genscript Biotech Corporation | -415.79 Million USD | 98.143% |
| Ember Therapeutics, Inc. | -17.42 Thousand USD | -44221.583% |
| Anthera Pharmaceuticals, Inc. | - USD | Infinity% |
| Sigyn Therapeutics, Inc. | -2.45 Million USD | -214.471% |
| WPD Pharmaceuticals Inc. | -171.5 Thousand USD | -4401.944% |
| Cotinga Pharmaceuticals Inc. | -2 Million USD | -285.147% |
| Kadimastem Ltd | -3.04 Million USD | -153.968% |
| Helix BioMedix, Inc. | -984.05 Thousand USD | -684.639% |
| VitaSpring Biomedical Co. Ltd. | - USD | Infinity% |
| Oncology Pharma Inc. | - USD | Infinity% |
| Reve Technologies, Inc. | -181.48 Thousand USD | -4154.491% |
| LadRx Corporation | -3.82 Million USD | -101.936% |
| Cell Source, Inc. | -4.32 Million USD | -78.512% |
| Regen BioPharma, Inc. | -686.95 Thousand USD | -1023.992% |
| NovAccess Global Inc. | -2.46 Million USD | -213.012% |
| Affymax, Inc. | -15.04 Million USD | 48.682% |
| Itoco Inc. | -919.14 Thousand USD | -740.053% |
| Rasna Therapeutics, Inc. | -4.23 Million USD | -82.173% |
| Pathfinder Cell Therapy, Inc. | -1.11 Million USD | -590.015% |
| Mobile Lads Corp. | -554.55 Thousand USD | -1292.347% |
| CytoDyn Inc. | -18.05 Million USD | 57.242% |
| Claritas Pharmaceuticals, Inc. | - USD | Infinity% |
| NDT Pharmaceuticals Inc. | -25.17 Thousand USD | -30576.452% |
| NanoSphere Health Sciences Inc. | -220.07 Thousand USD | -3408.421% |
| Alseres Pharmaceuticals, Inc. | -564.72 Thousand USD | -1267.266% |
| SYBLEU INC | -149.18 Thousand USD | -5075.803% |
| Advanced Proteome Therapeutics Corporation | - USD | Infinity% |
| ImmunoCellular Therapeutics, Ltd. | -1.81 Million USD | -325.105% |
| International Stem Cell Corporation | -663 Thousand USD | -1064.595% |
| Bioxytran, Inc. | -3.82 Million USD | -102.12% |
| GlobeImmune, Inc. | - USD | Infinity% |
| Predictive Technology Group, Inc. | - USD | Infinity% |
| ProText Mobility, Inc. | -52.64 Thousand USD | -14568.053% |
| Cardax, Inc. | - USD | Infinity% |
| VG Life Sciences Inc. | -20.34 Thousand USD | -37860.978% |
| Kaleido Biosciences, Inc. | - USD | Infinity% |
| Advaxis, Inc. | -36.26 Million USD | 78.709% |
| Adhera Therapeutics, Inc. | -1.61 Million USD | -377.21% |
| RenovaCare, Inc. | - USD | Infinity% |
| Regnum Corp. | -735.83 Thousand USD | -949.32% |
| Innovation Pharmaceuticals Inc. | -3.11 Million USD | -148.192% |
| Neutra Corp. | -229.48 Thousand USD | -3264.59% |
| Windtree Therapeutics, Inc. | -17.53 Million USD | 55.977% |
| PureTech Health plc | -146.19 Million USD | 94.719% |
| Coeptis Therapeutics, Inc. | -21.49 Million USD | 64.072% |
| IXICO plc | -1.43 Million USD | -437.318% |
| IntelGenx Technologies Corp. | -9.49 Million USD | 18.646% |
| Gelesis Holdings, Inc. | -121.8 Million USD | 93.661% |
| CSL Limited | 3.81 Billion USD | 100.203% |
| Cellectis S.A. | -108.85 Million USD | 92.907% |